Latest Takeda Pharmaceutical Company Limited Stories
OSAKA, Japan, May 15, 2015 /PRNewswire/ -- Operational guidance met - Underlying revenue +2.8% year-over-year, in line with guidance
Attorneys Richard J. Arsenault of Neblett, Beard & Arsenault and Paul J. Pennock of Weitz & Luxenberg were the court-appointed co-lead Plaintiffs' counsel in the Multi-District Litigation (No.
Attorney Neil Overholtz, of Aylstock, Witkin, Kreis & Overholtz, PLLC in Pensacola, Florida, a court-appointed member of the Plaintiffs’ Steering Committee in the Multi-District Litigation
TAIPEI, April 27, 2015 /PRNewswire/ -- TWi Pharmaceuticals, Inc.
KYOTO and OSAKA, Japan, April 16, 2015 /PRNewswire/ -- Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today
DEERFIELD, Ill. and OSAKA, Japan, April 14, 2015 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A. Inc.
OSAKA, Japan, March 9, 2015 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular
NEW YORK, March 9, 2015 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") today held a briefing for investors and analysts in New York, discussing the company's gastroenterology
Companies Committed to Providing Access to Colchicine Tablets CINCINNATI and DEERFIELD, Ill., Jan.